Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value
$488.62M
Total Bought
$127.75M
Total Sold
$159.07M
Net Transaction
-$31.32M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG ONCOLOGY INC(CGON)0541,034+541,034014,0672.88%+14,067
NEUROCRINE BIOSCIENCES INC(NBIX)72,583162,969+90,3868,02820,4844.19%+12,456
UROGEN PHARMA LTD(URGN)1,381,1582,022,482+641,32415,27627,7085.67%+12,432
SCHOLAR ROCK HLDG CORP(SRRK)0341,010+341,010012,0792.47%+12,079
VAXCYTE INC(PCVX)0287,796+287,79609,3561.91%+9,356
89BIO INC1,510,4982,037,087+526,58910,98120,0044.09%+9,023
AKERO THERAPEUTICS INC719,992713,811-6,18129,14538,0897.80%+8,944
PFIZER INC(PFE)0344,338+344,33808,3471.71%+8,347
RHYTHM PHARMACEUTICALS INC(RYTM)337,605400,772+63,16717,88325,3255.18%+7,442
ORIC PHARMACEUTICALS INC(ORIC)2,060,2401,800,829-259,41111,49618,2783.74%+6,782
SOLENO THERAPEUTICS INC166,417204,591+38,17411,89017,1413.51%+5,250
ABEONA THERAPEUTICS INC(ABEO)0917,898+917,89805,2141.07%+5,214
CIDARA THERAPEUTICS INC0103,943+103,94305,0631.04%+5,063
MERUS N V811,021741,972-69,04934,13639,0287.99%+4,892
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)082,023+82,02303,8710.79%+3,871
ASCENDIS PHARMA A/S(ASND)75,75186,552+10,80111,80714,9393.06%+3,132
AARDVARK THERAPEUTICS INC119,496286,807+167,3118973,8780.79%+2,980
METSERA INC112,759207,581+94,8223,0695,9061.21%+2,836
SIONNA THERAPEUTICS INC(SION)114,138186,015+71,8771,1943,2270.66%+2,033
TELA BIO INC(TELA)2,771,2882,779,795+8,5073,3815,3931.10%+2,012
ORUKA THERAPEUTICS INC(ORKA)0165,389+165,38901,8540.38%+1,854
TOURMALINE BIO INC0109,257+109,25701,7470.36%+1,747
COMPASS THERAPEUTICS INC(CMPX)874,8691,249,781+374,9121,6623,2490.67%+1,587
COMPUGEN LTD(CGEN)2,895,4303,033,879+138,4494,2275,4001.11%+1,173
KALVISTA PHARMACEUTICALS INC1,698,9841,832,171+133,18719,60620,7134.24%+1,106
UNIQURE NV(QURE)203,400202,565-8352,1562,8240.58%+668
INSMED INC(INSM)321,366249,060-72,30624,51725,0655.13%+548
STRUCTURE THERAPEUTICS INC188,069175,636-12,4333,2553,6430.75%+387
CELLDEX THERAPEUTICS INC NEW(CLDX)205,962198,441-7,5213,7384,0380.83%+300
SAGIMET BIOSCIENCES INC(SGMT)037,539+37,53902860.06%+286
KODIAK SCIENCES INC(KOD)441,807401,540-40,2671,2391,4980.31%+258
ENLIVEN THERAPEUTICS INC010,000+10,00002010.04%+201
KINIKSA PHARMACEUTICALS INTL(KNSA)88,21575,959-12,2561,9592,1020.43%+143
CERUS CORP(CERS)2,456,5372,488,291+31,7543,4153,5080.72%+94
FRACTYL HEALTH INC(GUTS)237,448202,590-34,8582833280.07%+46
NEKTAR THERAPEUTICS(NKTR)0346+346090.00%+9
ROCKET PHARMACEUTICALS INC(RCKT)104,828104,8280530.00%-2
RADIOPHARM THERANOSTICS LTD(RADX)187,406187,40609018700.18%-32
MERSANA THERAPEUTICS INC3,088,5053,128,421+39,9161,0639260.19%-137
VAXART INC(VXRT)683,8250-683,8252780—-278
BENITEC BIOPHARMA INC(BNTC)250,000253,234+3,2343,2532,9630.61%-290
AVADEL PHARMACEUTICALS PLC39,3660-39,3663080—-308
XENON PHARMACEUTICALS INC(XENE)10,1210-10,1213400—-340
TREVI THERAPEUTICS INC(TRVI)530,000539,587+9,5873,3342,9520.60%-382
HELIX ACQUISITION CORP II613,393613,39306,9316,5141.33%-417
AVIDITY BIOSCIENCES INC411,312410,000-1,31212,14211,6442.38%-498
MODULAR MED INC958,881710,363-248,5181,0455290.11%-516
GOSSAMER BIO INC(GOSS)6,320,6845,146,782-1,173,9026,9536,3311.30%-622
VERONA PHARMA PLC545,872358,297-187,57534,65733,8886.94%-770
DELCATH SYS INC(DCTH)191,470103,026-88,4442,4371,4010.29%-1,036
INFLARX NV(IFRX)1,161,5670-1,161,5671,1850—-1,185
ELUTIA INC(ELUT)2,670,0562,761,684+91,6286,7555,4681.12%-1,287
ABIVAX SA(ABVX)210,9010-210,9011,3180—-1,318
UNICYCIVE THERAPEUTICS INC2,413,4890-2,413,4891,3880—-1,388
KALA BIO INC(KALA)246,0790-246,0791,4100—-1,410
C4 THERAPEUTICS INC(CCCC)882,3000-882,3001,4120—-1,412
DIANTHUS THERAPEUTICS INC(DNTH)190,33495,806-94,5283,4531,7850.37%-1,668
SOLID BIOSCIENCES INC452,2390-452,2391,6730—-1,673
BIODESIX INC(BDSX)4,098,4061,070,367-3,028,0392,5623020.06%-2,260
PTC THERAPEUTICS INC(PTCT)60,3890-60,3893,0770—-3,077
LIQUIDIA CORPORATION(LQDA)214,0570-214,0573,1570—-3,157
CENTESSA PHARMACEUTICALS PLC232,7585,000-227,7583,347660.01%-3,281
BLUEPRINT MEDICINES CORP37,3450-37,3453,3050—-3,305
MADRIGAL PHARMACEUTICALS INC(MDGL)10,3440-10,3443,4260—-3,426
MINERALYS THERAPEUTICS INC(MLYS)338,354115,282-223,0725,3731,5600.32%-3,813
KURA ONCOLOGY INC(KURA)581,3690-581,3693,8370—-3,837
BRIDGEBIO PHARMA INC(BBIO)111,0000-111,0003,8370—-3,837
OCULAR THERAPEUTIX INC(OCUL)551,5700-551,5704,0430—-4,043
ALKERMES PLC(ALKS)124,8710-124,8714,1230—-4,123
TARSUS PHARMACEUTICALS INC(TARS)81,3310-81,3314,1780—-4,178
PRAXIS PRECISION MEDICINES I(PRAX)166,07410,000-156,0746,2894210.09%-5,869
VERACYTE INC(VCYT)633,832448,495-185,33718,79312,1232.48%-6,670
ERASCA INC(ERAS)7,367,9962,569,591-4,798,40510,0943,2630.67%-6,831
GILEAD SCIENCES INC(GILD)62,0290-62,0296,9500—-6,950
TRAVERE THERAPEUTICS INC(TVTX)408,8490-408,8497,3270—-7,327
WAVE LIFE SCIENCES LTD(WVE)1,050,3740-1,050,3748,4870—-8,487
DISC MEDICINE INC(IRON)236,4710-236,47111,7380—-11,738
SYNDAX PHARMACEUTICALS INC(SNDX)1,309,224402,964-906,26016,0843,7740.77%-12,310
NUVALENT INC439,018235,583-203,43531,13517,9753.68%-13,160
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q2 2025 | TickerTrail